Title : Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study - Apostol_2012_Psychopharmacology.(Berl)_219_715
Title : ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit\/hyperactivity disorder in adults: results of a pilot study - Wilens_2006_Biol.Psychiatry_59_1065